Guidance on responding to potential adverse reactions to COVID-19 vaccine
Updated: 22 January 2022
Recipients of the vaccine may present with concerns about a suspected adverse event following immunisation (AEFI) or you may suspect their presenting complaint could be related to the vaccine.
NSW Health has provided the following information on responding to potential adverse reactions:
Guidance on investigation or management support
Guidance on investigation or management support, and on reporting requirements, is available on the NSW Health COVID-19 vaccination website and through the NSW Immunisation Specialist Service (NSWISS) on 1800 679 477 (9am to 5pm).
COVID-19 Risk Monitoring Dashboard
A weekly dashboard published by NSW Agency for Clinical Innovation's COVID-19 Critical Intelligence Unit focusing on transmission risk in healthcare settings. The dashboard brings together data on cases, clusters, the public health response, and the impact of COVID-19 on the workforce. An expert panel reviews the dashboard and assigns a risk rating.
Thrombosis with thrombocytopaenia syndrome (TTS)
Primary care approach to thrombosis with thrombocytopenia syndrome after COVID-19 AstraZeneca vaccine.
AEFI are a notifiable condition under the NSW Public Health Act (2010). All uncommon, unexpected or serious AEFI, or any event considered by a clinician to be significant following immunisation, must be notified to the local Public Health Unit on 1300 066 055 or by email to MOHfirstname.lastname@example.org using the TGA AEFI case notification form.
If your patient has had a COVID-19 vaccination and think they may be experiencing side-effects, check the Healthdirect COVID-19 Vaccine Side Effects Symptom Checker website.
Department of Health Weekly Vaccine Safety Reports
DoH COVID-19 Vaccine Weekly Safety Reports look for latest weekly safety report on the Department of Health News and Updates web page.
Selected Adverse Events Reported after COVID-19 Vaccination
Centers for Disease Control and Prevention website: Selected Adverse Events Reported after COVID-19 Vaccination